ALPN
Alpine Immune Sciences, Inc. Common Stock
ALPN
ALPN
Delisted
ALPN was delisted on the 17th of May, 2024.
53 hedge funds and large institutions have $257M invested in Alpine Immune Sciences, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 21 increasing their positions, 9 reducing their positions, and 4 closing their positions.
Holders
53
Holders Change
+9
Holders Change %
+20.45%
% of All Funds
0.82%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.05%
New
13
Increased
21
Reduced
9
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
LGM
1
Logos Global Management
San Francisco,
California
|
$15.5M |
2 |
ACP
2
Acuta Capital Partners
Redwood City,
California
|
$3.19M |
3 |
3
BlackRock
New York
|
$10.1M |
4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$9.66M |
5 |
5
Walleye Capital
New York
|
$1.53M |